280. Huge arteriovenous malformation with cervicofacial or limb lesion Clinical trials / Disease details


Clinical trials : 27 Drugs : 30 - (DrugBank : 15) / Drug target genes : 14 - Drug target pathways : 153

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05125471
(ClinicalTrials.gov)
July 26, 202212/11/2021Cobimetinib In Extracranial Arteriovenous Malformations (COBI-AVM Study)COBI-AVM Study - Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib In Extracranial Arteriovenous Malformations (AVM)Arteriovenous Malformations (Extracranial)Drug: CobimetinibUniversity of ArkansasGenentech, Inc.Recruiting2 Years80 YearsAll17Phase 2United States